
The Cochrane Scizophrenia Group have updated the systematic review that brings together all randomised controlled trials (RCTs) designed to prevent progression to psychosis in people showing prodromal symptoms, or to improve outcome for people with first-episode psychosis. The reviewers found 18 RCTs this time around, but (as is often the case with systematic reviews) the [read the full story…]